T-cell tolerance in allergic response

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 9, 2002, Pages 762-768

  Schmidt Weber, C B ^a   Blaser, K ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; HYPERSENSITIVITY; IMMUNOLOGY;

ALLERGENS; ANIMAL; ANTIGEN-PRESENTING CELLS; CYTOKINES; HUMAN; HYPERSENSITIVITY; IMMUNE TOLERANCE; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; ANIMALS; HUMANS;

ALLERGEN; CYTOKINE;

EID: 0036724011     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.02158.x     Document Type: Review

References (92)

1. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
2. Determinants and mechanisms of human immune responses to bee venom phospholipase A2
3. Allergen-specific immunotherapy for allergic rhinitis: A new insight into its clinical efficacy and mechanism
4. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms
5. Peripheral tolerance as a multistep mechanism
6. Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires
7. Infectious tolerance
8. What is the role of regulatory T cells in transplantation tolerance?
9. Induction and mechanism of action of transforming growth factor- beta- secreting Th3 regulatory cells
10. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of smad7 enhances antigen-induced airway inflammation and airway reactivity
11. An interleukin (IL) -10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
12. Altered immune responses in interleukin 10 transgenic mice
13. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement
14. T cells in allergy and anergy
15. Mechanisms of interleukin-10-mediated immune suppression
16. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens
17. The role of interleukin 10 in the regulation of allergic immune responses
18. IL-10 and TGF-b cooperate in inducing peripheral T cell tolerance during specific immunotherapy with inhalant allergens and during natural allergen exposure
19. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals
20. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
21. Mechanisms of T cell peptide epitope-dependent late asthmatic reactions
22. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13
23. Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56 (lck) and ZAP-70 tyrosine kinase activities
24. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling
25. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells
26. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
27. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro
28. Induction of T cell anergy by high concentrations of immunodominant native peptide is accompanied by IL-10 production and a block in JNK activity
29. Ex vivo isolation and characterization of CD4 (+) CD25 (+) T cells with regulatory properties from human blood
30. Human cd25 (+) cd4 (+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
31. Human CD4 (+) CD25 (+) cells: A naturally occurring population of regulatory T cells
32. Control of T-cell activation by CD4+ CD25+ suppressor T cells
33. Anergic T cells effect linked suppression
34. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized In vivo
35. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
36. Cd4 (+) cd25 (+) t cells facilitate the induction of t cell anergy
37. A Cd4 (+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
38. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells
39. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation
40. Cytokine gene activation in synovial membrane, regional lymph nodes, and spleen during the course of rat adjuvant arthritis
41. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
42. Dendritic cells as a tool to induce anergic and regulatory T cells
43. Induction of tolerance by IL-10-treated dendritic cells
44. Designer dendritic cells for tolerance induction: Guided not misguided missiles
45. Tolerance and bystander suppression, with involvement of CD25-positive cells, is induced in rats receiving serum from ovalbumin-fed donors
46. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells
47. The expanding world of co-stimulation: The two-signal model revisited
48. CD4+ CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells
49. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
50. IL-10 enhances expression of the IL-2 receptor alpha chain on T cells
51. Regulation of TGF-beta response during T cell activation is modulated by IL-10
52. Interleukin-10-deficient mice develop chronic enterocolitis
53. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
54. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
55. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulating pathway
56. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells
57. Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation
58. TGF-beta influences the life and death decisions of T lymphocytes
59. The effect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells
60. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1
61. Dna arrays in allergy and immunology
62. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells
63. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway
64. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production
65. Differentiation of T regulatory cells by immature dendritic cells
66. Activation of STAT4 by IL-12 and IFN-alpha: Evidence for the involvement of ligand-induced tyrosine and serine phosphorylation
67. Treatment with IFN-alpha in corticosteroid-unresponsive asthma
68. IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells
69. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4 (+) T cells
70. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection
71. Is CTLA-4 a master switch for peripheral T cell tolerance?
72. Costimulation in tolerance and autoimmunity
73. B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance
74. Inhibition of dendritic cell costimulation associated with tolerance to allografts
75. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
76. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling
77. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
78. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD-28 tyrosine phosphorylation and phosphatidylinositol 3-kinease binding
79. Immune inhibitory receptors
80. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond
81. Differential susceptibility of human T (h) 1 versus T (h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen- presenting cells
82. Induction of anergy in Th1 lymphocytes by oral tolerance. Importance of antigen dosage and frequency of feeding
83. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
84. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12
85. Regulatory T cells: Key controllers of immunologic self-tolerance
86. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
87. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization
88. Costimulation with dexamethasone and prostaglandin E2, a novel paradigm for the induction of T-cell anergy
89. Prostaglandin E2 promotes the induction of anergy during T helper cell recognition of myelin basic protein
90. Prostaglandin E2 inhibits SEB-mediated induction of the cutaneous lymphocyte-associated antigen
91. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice
92. Prostaglandin D2 as a mediator of allergic asthma